Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Liraglutide (Saxenda) NICE Technology Appraisal TA664 recommends liraglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, within a specialist weight management service
doi: 10.1155/2021/6696542 168
Serious but rare risks include pancreatitis, gallbladder disease, acute kidney injury secondary to dehydration, and hypersensitivity reactions
These are unstable molecules that can damage cells, proteins, and DNA if left unchecked
In another major analysis, researchers examined more than 30 million FDA adverse event reports to identify potential safety signals linked to GLP-1 drugs
US$ 25.33
US$ 27.81
US$ 21.60
